Poland โ€“ 69-PN-26 Active substance Laronidase as part of the Drug Program - Treatment of Hurler Disease, Drugs in the Drug Program - Treatment of Hurler Disease

By: Municipal Hospital in Gliwice Sp.z o. o.๐Ÿ“ PolandOpen

Key Information

ReferenceGB-798500-2026
DeadlineDec 18, 2026 12:00 AM
CategoryAdvertising & Media
Competition TypeICB
Funding SourceSelf-Funded
CountryPoland
AddressZygmunta Starego 20, Gliwice, 44-100, Poland
PublishedNov 17, 2026

Description

2. Procedure2.1.ProcedureTitle: 69-PN-26 Active substance Laronidase as part of the Drug Program - Treatment of Hurler Disease, Drugs in the Drug Program - Treatment of Hurler DiseaseDescription: The ...

Full details are available after unlocking this tender.